Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP)

Muhammad Imran Omar, Thomas B Lam, Cameron E Alexander, John Graham, Charalampos Mamoulakis, Mari Imamura, Steven Maclennan, Fiona Stewart, James N'dow

Research output: Contribution to journalArticle

47 Citations (Scopus)

Abstract

To compare monopolar and bipolar transurethral resection of the prostate (TURP) for clinical effectiveness and adverse events.
We conducted an electronic search of MEDLINE, Embase, CENTRAL, Science Citation Index, and also searched reference lists of articles and abstracts from conference proceedings for randomised controlled trials (RCTs) comparing monopolar and bipolar TURP.
Two reviewers independently undertook data extraction and assessed the risk of bias in the included trials using the tool recommended by the Cochrane Collaboration.
The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach.
From the 949 abstracts that were identified, 94 full texts were assessed for eligibility and a total of 24 trials were included in the review.
No statistically significant differences were found in terms of International Prostate Symptom Score (IPSS) or health-related quality of life (HRQL) score.
Results for maximum urinary flow rate were significant at 3, 6 and 12 months (all P < 0.001), but no clinically significant differences were found and the meta-analysis showed evidence of heterogeneity
Bipolar TURP was associated with fewer adverse events including transurethral resection syndrome (risk ratio [RR] 0.12, 95% confidence interval [CI] 0.05–0.31, P < 0.001), clot retention (RR 0.48, 95% CI 0.30–0.77, P = 0.002) and blood transfusion (RR 0.53, 95% CI 0.35–0.82, P = 0.004)
Several major methodological limitations were identified in the included trials; 22/24 trials had a short follow-up of ≤1 year, there was no evidence of a sample size calculation in 20/24 trials and the application of GRADE showed the evidence for most of the assessed outcomes to be of moderate quality, including all those in which statistical differences were found.
Whilst there is no overall difference between monopolar and bipolar TURP for clinical effectiveness, bipolar TURP is associated with fewer adverse events and therefore has a superior safety profile.
Various methodological limitations were highlighted in the included trials and as such the results of this review should be interpreted with caution.
There is a need for further well-conducted, multicentre RCTs with long-term follow-up data.
Original languageEnglish
Pages (from-to)24-35
Number of pages12
JournalBJU International
Volume113
Issue number1
Early online date24 Oct 2013
DOIs
Publication statusPublished - Jan 2014

Fingerprint

Transurethral Resection of Prostate
Meta-Analysis
Odds Ratio
Confidence Intervals
Randomized Controlled Trials
MEDLINE
Blood Transfusion
Sample Size
Prostate
Quality of Life
Safety

Keywords

  • monopolar
  • bipolar
  • transurethral resection of the prostate (TURP)
  • benign prostatic enlargement
  • systematic review
  • meta-analysis

Cite this

Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP). / Omar, Muhammad Imran; Lam, Thomas B; Alexander, Cameron E; Graham, John; Mamoulakis, Charalampos; Imamura, Mari; Maclennan, Steven; Stewart, Fiona; N'dow, James.

In: BJU International, Vol. 113, No. 1, 01.2014, p. 24-35.

Research output: Contribution to journalArticle

@article{f5492337333d458b831d045221fc35de,
title = "Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP)",
abstract = "To compare monopolar and bipolar transurethral resection of the prostate (TURP) for clinical effectiveness and adverse events. We conducted an electronic search of MEDLINE, Embase, CENTRAL, Science Citation Index, and also searched reference lists of articles and abstracts from conference proceedings for randomised controlled trials (RCTs) comparing monopolar and bipolar TURP. Two reviewers independently undertook data extraction and assessed the risk of bias in the included trials using the tool recommended by the Cochrane Collaboration. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. From the 949 abstracts that were identified, 94 full texts were assessed for eligibility and a total of 24 trials were included in the review. No statistically significant differences were found in terms of International Prostate Symptom Score (IPSS) or health-related quality of life (HRQL) score. Results for maximum urinary flow rate were significant at 3, 6 and 12 months (all P < 0.001), but no clinically significant differences were found and the meta-analysis showed evidence of heterogeneity Bipolar TURP was associated with fewer adverse events including transurethral resection syndrome (risk ratio [RR] 0.12, 95{\%} confidence interval [CI] 0.05–0.31, P < 0.001), clot retention (RR 0.48, 95{\%} CI 0.30–0.77, P = 0.002) and blood transfusion (RR 0.53, 95{\%} CI 0.35–0.82, P = 0.004) Several major methodological limitations were identified in the included trials; 22/24 trials had a short follow-up of ≤1 year, there was no evidence of a sample size calculation in 20/24 trials and the application of GRADE showed the evidence for most of the assessed outcomes to be of moderate quality, including all those in which statistical differences were found. Whilst there is no overall difference between monopolar and bipolar TURP for clinical effectiveness, bipolar TURP is associated with fewer adverse events and therefore has a superior safety profile. Various methodological limitations were highlighted in the included trials and as such the results of this review should be interpreted with caution. There is a need for further well-conducted, multicentre RCTs with long-term follow-up data.",
keywords = "monopolar, bipolar, transurethral resection of the prostate (TURP), benign prostatic enlargement, systematic review, meta-analysis",
author = "Omar, {Muhammad Imran} and Lam, {Thomas B} and Alexander, {Cameron E} and John Graham and Charalampos Mamoulakis and Mari Imamura and Steven Maclennan and Fiona Stewart and James N'dow",
note = "{\circledC} 2013 The Authors. BJU International {\circledC} 2013 BJU International.",
year = "2014",
month = "1",
doi = "10.1111/bju.12281",
language = "English",
volume = "113",
pages = "24--35",
journal = "BJU International",
issn = "1464-4096",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Systematic review and meta-analysis of the clinical effectiveness of bipolar compared with monopolar transurethral resection of the prostate (TURP)

AU - Omar, Muhammad Imran

AU - Lam, Thomas B

AU - Alexander, Cameron E

AU - Graham, John

AU - Mamoulakis, Charalampos

AU - Imamura, Mari

AU - Maclennan, Steven

AU - Stewart, Fiona

AU - N'dow, James

N1 - © 2013 The Authors. BJU International © 2013 BJU International.

PY - 2014/1

Y1 - 2014/1

N2 - To compare monopolar and bipolar transurethral resection of the prostate (TURP) for clinical effectiveness and adverse events. We conducted an electronic search of MEDLINE, Embase, CENTRAL, Science Citation Index, and also searched reference lists of articles and abstracts from conference proceedings for randomised controlled trials (RCTs) comparing monopolar and bipolar TURP. Two reviewers independently undertook data extraction and assessed the risk of bias in the included trials using the tool recommended by the Cochrane Collaboration. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. From the 949 abstracts that were identified, 94 full texts were assessed for eligibility and a total of 24 trials were included in the review. No statistically significant differences were found in terms of International Prostate Symptom Score (IPSS) or health-related quality of life (HRQL) score. Results for maximum urinary flow rate were significant at 3, 6 and 12 months (all P < 0.001), but no clinically significant differences were found and the meta-analysis showed evidence of heterogeneity Bipolar TURP was associated with fewer adverse events including transurethral resection syndrome (risk ratio [RR] 0.12, 95% confidence interval [CI] 0.05–0.31, P < 0.001), clot retention (RR 0.48, 95% CI 0.30–0.77, P = 0.002) and blood transfusion (RR 0.53, 95% CI 0.35–0.82, P = 0.004) Several major methodological limitations were identified in the included trials; 22/24 trials had a short follow-up of ≤1 year, there was no evidence of a sample size calculation in 20/24 trials and the application of GRADE showed the evidence for most of the assessed outcomes to be of moderate quality, including all those in which statistical differences were found. Whilst there is no overall difference between monopolar and bipolar TURP for clinical effectiveness, bipolar TURP is associated with fewer adverse events and therefore has a superior safety profile. Various methodological limitations were highlighted in the included trials and as such the results of this review should be interpreted with caution. There is a need for further well-conducted, multicentre RCTs with long-term follow-up data.

AB - To compare monopolar and bipolar transurethral resection of the prostate (TURP) for clinical effectiveness and adverse events. We conducted an electronic search of MEDLINE, Embase, CENTRAL, Science Citation Index, and also searched reference lists of articles and abstracts from conference proceedings for randomised controlled trials (RCTs) comparing monopolar and bipolar TURP. Two reviewers independently undertook data extraction and assessed the risk of bias in the included trials using the tool recommended by the Cochrane Collaboration. The quality of evidence was assessed using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. From the 949 abstracts that were identified, 94 full texts were assessed for eligibility and a total of 24 trials were included in the review. No statistically significant differences were found in terms of International Prostate Symptom Score (IPSS) or health-related quality of life (HRQL) score. Results for maximum urinary flow rate were significant at 3, 6 and 12 months (all P < 0.001), but no clinically significant differences were found and the meta-analysis showed evidence of heterogeneity Bipolar TURP was associated with fewer adverse events including transurethral resection syndrome (risk ratio [RR] 0.12, 95% confidence interval [CI] 0.05–0.31, P < 0.001), clot retention (RR 0.48, 95% CI 0.30–0.77, P = 0.002) and blood transfusion (RR 0.53, 95% CI 0.35–0.82, P = 0.004) Several major methodological limitations were identified in the included trials; 22/24 trials had a short follow-up of ≤1 year, there was no evidence of a sample size calculation in 20/24 trials and the application of GRADE showed the evidence for most of the assessed outcomes to be of moderate quality, including all those in which statistical differences were found. Whilst there is no overall difference between monopolar and bipolar TURP for clinical effectiveness, bipolar TURP is associated with fewer adverse events and therefore has a superior safety profile. Various methodological limitations were highlighted in the included trials and as such the results of this review should be interpreted with caution. There is a need for further well-conducted, multicentre RCTs with long-term follow-up data.

KW - monopolar

KW - bipolar

KW - transurethral resection of the prostate (TURP)

KW - benign prostatic enlargement

KW - systematic review

KW - meta-analysis

U2 - 10.1111/bju.12281

DO - 10.1111/bju.12281

M3 - Article

VL - 113

SP - 24

EP - 35

JO - BJU International

JF - BJU International

SN - 1464-4096

IS - 1

ER -